Veradermics Presents New Phase 2/3 Data Highlighting the Potential of VDPHL01 for Male Pattern Hair Loss Across Age Groups Veradermics, Incorporated, a late-stage biopharmaceutical company founded by dermatologists and dedicated…
LianMedical Completes Merger with LianBio and Launches New Chapter as Medical Device Innovation Company LianMedical, formerly known as LianBio, has announced the successful completion of its previously disclosed corporate merger,…
Takeda Reports New Phase 3 Data Showing Zasocitinib Delivers Strong Skin Clearance Across Difficult-to-Treat Areas in Plaque Psoriasis Takeda has announced new findings from its two pivotal Phase 3 clinical…
Mirador Therapeutics Expands Precision Immunology Pipeline Through Global Licensing Agreement for KP-301 Mirador Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision medicines for immune-mediated inflammatory and fibrotic diseases,…
Cutera and Restimulate Health Partner to Advance Technology-Driven Rehabilitation with truFlex Integration CUTERA, INC., a global provider of aesthetic and dermatologic technologies, has announced a strategic partnership with Restimulate Health,…
Anova Enterprises and Nouveau Biosciences Partner to Advance Clinical Development of Kromastat for Hard-to-Treat Cancers Anova Enterprises, Inc., a technology-enabled contract research organization (CRO) dedicated to accelerating the development of…
Agenus Secures Up to $340 Million in Private Financing to Advance Phase 3 ROBBIN Trial for MSS Colon Cancer Agenus Inc., a biotechnology company focused on developing innovative immuno-oncology therapies,…
Aqtual Strengthens Executive Leadership to Advance Active Chromatin cfDNA Diagnostics and Precision Medicine Platform Aqtual, Inc., a precision medicine company focused on developing next-generation diagnostics based on active chromatin cell-free…
TruTechnologies Unveils New Brand Identity as It Advances Real-Time Clinical Trial Innovation TruTechnologies, a clinical trial software company specializing in real-time visibility into trial execution at the point of care,…
Kairos Pharma Reports Encouraging Phase 1 Safety Results for ENV-105 Combined with Osimertinib in EGFR-Mutated Lung Cancer Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing therapies to overcome…
Zoetis Launches Lenivia® in Europe and Canada to Provide Long-Acting Osteoarthritis Pain Relief for Dogs Zoetis Inc., a global leader in animal health, has announced the commercial launch of Lenivia®…
Corrixr Therapeutics Appoints Nancy Whiting as Board Chair to Support Advancement of CXR101 Toward Clinical Development Corrixr Therapeutics, a preclinical genetic medicine company developing innovative therapies for squamous cell cancers,…